Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAMB vs PBMT for H. pylori Eradication
NCT03665428Phase 4Completed
- Sponsor
- Hallym University Chuncheon Sacred Heart Hospital
- Start
- Jul 2018
- Primary completion
- Aug 2019
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of rabeprazole, amoxicillin, metronidazole, bismuth subcitrate in Helicobacter pylori infection, sponsored by Hallym University Chuncheon Sacred Heart Hospital. Started Jul 2018; status: completed.
02
Drugs
rabeprazoleamoxicillinmetronidazolebismuth subcitrate
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT03665428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03665428.